Trial intelligence / Profile preview

Seroquel Potentiation of SSRI/SNRI in Major Depression with Anxiety

NCT00229645Phase 4Completed

Sponsor
Dr. Alexander McIntyre
Start
Nov 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of quetiapine in major depressive disorder (MDD), anxiety disorder, sponsored by Dr. Alexander McIntyre. Started Nov 2003; status: completed.

02

Drugs

quetiapine
03

Conditions

major depressive disorder (MDD)anxiety disorder

Beyond the preview

Go deeper on NCT00229645.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00229645.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call